Neil Woodford (Woodford Investment Management via YouTube)

Neil Wood­ford in the game to buy back his for­mer un­list­ed port­fo­lio that's prov­ing hard to sell — re­ports

As bro­kers strug­gle to of­fload the port­fo­lio of as­sets for­mer­ly man­aged by Neil Wood­ford, an un­like­ly buy­er has emerged.

The dis­graced stock­pick­er is re­port­ed­ly gaug­ing in­vestor in­ter­est in a come­back bid to reac­quire some of those un­list­ed com­pa­ny stakes, in­clud­ing eq­ui­ty in drug dis­cov­ery start­up Benev­o­len­tAI and TCR play­er Im­muno­core.

If he man­ages to pull enough fund­ing — £500 mil­lion (close to $720 mil­lion) would be re­quired — Wood­ford would set up a new ve­hi­cle to buy back his dar­lings at a dis­count. The tar­get au­di­ence will be pro­fes­sion­al, so­phis­ti­cat­ed back­ers rather than re­tail in­vestors.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.